University of Dundee, MSc Human Clinical Embryology and Assisted Conception - Apply now for September 2018
Page URL: https://www.bionews.org.uk/page_136277

CRISPR scientists win prestigious $1m Kavli award

4 June 2018
Appeared in BioNews 952

Three scientists will share the US$1 million 2018 Kavli Prize in Nanoscience 'for the invention of CRISPR/Cas9, a precise nanotool for editing DNA, causing a revolution in biology, agriculture, and medicine'.

Professors Jennifer Doudna at the University of California, Berkeley and Emmanuelle Charpentier of the Max Planck Institute in Germany are well-known names associated with the discovery of CRISPR, but Professor Virginijus Šikšnys of Vilnius University in Lithuania has had a much lower public profile.

Professor Šikšnys discovered the properties and potential of CRISPR and Cas9 independently from Professors Doudna and Charpentier around the same time, but his paper was rejected by Cell and was not peer-reviewed. While he was seeking another publisher, Professors Doudna and Charpentier's paper was published in Science. His inclusion recognises his work and that he could easily have been the first to publish.

'These scientists were the first to understand this system could be engineered as a genome-editing tool with ease and flexibility and precision that could not have been achieved previously,' said Jacob Sherkow, of Stanford Law School who has closely followed CRISPR.

The award notably does not include Dr Feng Zhang of the Massachusetts Institute of Technology among the laureates. Dr Zhang's work, building on the published findings of Professors Doudna and Charpentier, showed that Cas9 can be used to edit the genome of eukaryotic cells. 

This has generated interest because the intellectual property around CRISPR and its application for genome editing has been hotly disputed, both in the court and also in public discussion about who will ultimately be awarded the Nobel prize for its discovery.

Dr Zhang's work forms the basis of MIT and the Broad Institute's claim to patent the use of CRISPR genome editing in eukaryotic cells (including human, animal and plant cells). The patent is disputed by UC Berkeley based on the work of Professors Doudna and Charpentier's group. US courts have so far sided with the Broad, but appeals are ongoing (see BioNews 948). Patents in China and Europe have been awarded to Berkeley (see BioNews 907 and 895). 

The three Kavli Prizes – Astrophysics, Nanoscience and Neuroscience – are awarded biennially.

SOURCES & REFERENCES
2018 Kavli Prize in Nanoscience
Kavli Foundation |  22 May 2018
Million-dollar Kavli prize recognizes scientist scooped on CRISPR
Nature News |  31 May 2018
Who gets credit for CRISPR? Prestigious award singles out three, and leaves out a notable scientist
STAT News |  31 May 2018
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
10 September 2018 - by Dr Kimberley Bryon-Dodd 
Seven scientists from the USA and the UK have shared the largest annual award related to vision research...
7 May 2018 - by Dr Sam Sherratt 
After three years of intense legal battles over the patent rights to CRISPR genome editing technology, lawyers for the University of California Berkeley and the Broad Institute in Cambridge, Massachusetts faced off in court again...
3 July 2017 - by Rachel Siden 
China's State Intellectual Property Office has granted the University of California a patent on CRISPR-Cas9 gene editing technology in the country.
2 May 2017 - by Brian Nolan 
The European Patent Office and the United States Patent and Trademark Office have been thrust into a dispute pitting the University of California, Berkeley and the University of Vienna against the Broad Institute of MIT and Harvard University. Scientists and inventors have been watching the decisions of the EPO and USPTO because these decisions may leave one of these entities with a patent portfolio worth billions of dollars...
3 April 2017 - by Jennifer Willows 
The European Patent Office has declared that it intends to grant a broad patent for the use of CRISPR technologies to the University of California, the University of Vienna and Dr Emmanuelle Charpentier of the Max-Planck Institute in Berlin...
6 February 2017 - by Dr Linda Wijlaars 
Professors Jennifer Doudna and Emmanuelle Charpentier have won the 2017 Japan Prize for their work on the genome-editing technology CRISPR/Cas9....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.